Intchains Group
ICG
Mawson Infrastructure
MIGI
Ebang International
EBON
Argo Blockchain
ARBK
Hive Blockchain
HIVE
US Stock MarketDetailed Quotes
ARVN Arvinas
- 18.890
- -0.280-1.46%
Close Jan 2 16:00 ET
- 19.200
- +0.310+1.64%
Post 20:01 ET
1.30BMarket Cap-3.94P/E (TTM)
20.110High18.745Low670.32KVolume19.540Open19.170Pre Close12.92MTurnover1.17%Turnover RatioLossP/E (Static)68.71MShares53.08052wk High2.22P/B1.08BFloat Cap17.37052wk Low--Dividend TTM57.26MShs Float108.465Historical High--Div YieldTTM7.12%Amplitude10.190Historical Low19.273Avg Price1Lot Size
About Arvinas Company
Arvinas, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its product candidates are ARV-110, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor (AR) protein for the treatment of men with metastatic castration-resistant prostate cancer, ARV-471, and ARV-766, a PROTAC protein degrader targeting the estrogen receptor protein for the treatment of patients with metastatic ER positive/HER2 negative breast cancer. The company was founded in February 2013 and is headquartered in New Haven, CT.
Company Profile
SymbolARVN
Company NameArvinas
Listing DateSep 27, 2018
Issue Price16.00
Founded2013
CEODr. John G. Houston, PhD
MarketNASDAQ
Employees445
Fiscal Year Ends12-31
Address5 Science Park,395 Winchester Avenue
CityNew Haven
ProvinceConnecticut
CountryUnited States of America
Zip Code06511
Phone1-203-535-1456
Websitehttp://www.arvinas.com
Company Executives
- Name
- Position
- Salary
- Dr. John G. Houston, PhD
- Chairman of the Board, President and Chief Executive Officer
- 7.63M
- David Loomis
- Vice President and Chief Accounting Officer
- --
- Dr. Noah Berkowitz, M.D.
- Chief Medical Officer
- --
- Andrew Saik
- Chief Financial Officer and Treasurer
- --
- Dr. Angela Cacace, PhD
- Chief Scientific Officer
- --
- Randy Teel, PhD
- Chief Business Officer
- --
- Dr. Ian Taylor, PhD
- President, Research and Development
- 2.73M
- Everett V. Cunningham
- Independent Director
- 350.00K
- Linda C. Bain
- Independent Director
- 370.00K
- Dr. Sunil Agarwal, M.D.
- Independent Director
- 784.74K
- Dr. Briggs W. Morrison, M.D.
- Lead Independent Director
- 383.54K
- Edward Kennedy, Jr
- Independent Director
- 345.41K
- Dr. Laurie Smaldone Alsup, M.D.
- Independent Director
- 430.30K
- Leslie V. Norwalk, Esq.
- Independent Director
- 350.00K
- John Douglas Young
- Independent Director
- 422.49K
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.